GlobeNewswire Inc | Jul 22, 2021 09:00AM EDT

July 22, 2021

NEWPORT BEACH, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2021 financial results and provide a business update onWednesday, August 4, 2021, after the close of the U.S. financial markets.

Management will host a conference call and live webcast to discuss Evolus financial results at4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks.

To participate in the conference call, dial (877) 407-6184 (U.S.) or (201) 389-0877 (international) or connect to the live webcast via the link on the Investor Relations page of theEvoluswebsite at www.evolus.com.

Following the completion of the call, a telephonic replay can be accessed by dialing (877) 660-6853 (U.S.) or (201) 612-7415 (international). An archived webcast can also be accessed on the Investor Relations page of theEvoluswebsite at www.evolus.com.

AboutEvolus, Inc.

Evolusis a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, theU.S. Food and Drug Administrationapproved Jeuveau(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveauis powered byEvolus'unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us atwww.evolus.com.

Jeuveauis a registered trademark ofEvolus, Inc.

Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:David K. Erickson, Evolus, Inc.Vice President, Investor RelationsTel: +1-949-966-1798Email: IR@Evolus.com

Media Contact:Crystal Muilenburg, Evolus, Inc.Chief Marketing OfficerTel: +1-949-284-4506Email: media@evolus.com